These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24697592)

  • 21. Assessing dose-region profile of drug efficacy: a multiregional trial strategy.
    Chen YH; Wang M
    J Biopharm Stat; 2012 Sep; 22(5):894-902. PubMed ID: 22946938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical design of noninferiority multiple region clinical trials to assess global and consistent treatment effects.
    Diao G; Zeng D; Ibrahim JG; Rong A; Lee O; Zhang K; Chen Q
    J Biopharm Stat; 2017; 27(6):933-944. PubMed ID: 28296570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sample size allocation to regions in a multiregional trial.
    Uesaka H
    J Biopharm Stat; 2009 Jul; 19(4):580-94. PubMed ID: 20183427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Informed consent. Trials that use Zelen's procedure should be acceptable.
    House A; Knapp P
    BMJ; 1997 Jul; 315(7102):251. PubMed ID: 9253287
    [No Abstract]   [Full Text] [Related]  

  • 25. Sequence balance minimisation: minimising with unequal treatment allocations.
    Madurasinghe VW
    Trials; 2017 May; 18(1):207. PubMed ID: 28468678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementing unequal randomization in clinical trials with heterogeneous treatment costs.
    Sverdlov O; Ryeznik Y
    Stat Med; 2019 Jul; 38(16):2905-2927. PubMed ID: 31049999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An empirical Bayes approach to evaluation of results for a specific region in multiregional clinical trials.
    Huang Y; Chang WJ; Hsiao CF
    Pharm Stat; 2013; 12(2):59-64. PubMed ID: 23319408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An automated patient registration and treatment randomization system.
    Papaconstantinou C; Krischer JP
    J Med Syst; 1995 Dec; 19(6):445-56. PubMed ID: 8750375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Step-forward randomization in multicenter emergency treatment clinical trials.
    Zhao W; Ciolino J; Palesch Y
    Acad Emerg Med; 2010 Jun; 17(6):659-65. PubMed ID: 20624149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unified additional requirement in consideration of regional approval for multiregional clinical trials.
    Teng Z; Chen YF; Chang M
    J Biopharm Stat; 2017; 27(6):903-917. PubMed ID: 28287339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of Zelen's design in randomised trials.
    Torgerson D
    BJOG; 2004 Jan; 111(1):2. PubMed ID: 14687043
    [No Abstract]   [Full Text] [Related]  

  • 32. The relative efficiency of Zelen's prerandomization design for clinical trials.
    Anbar D
    Biometrics; 1983 Sep; 39(3):711-8. PubMed ID: 6652204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2012 Jun; 73(6):856-64. PubMed ID: 22687813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is Zelen's design?
    Torgerson DJ; Roland M
    BMJ; 1998 Feb; 316(7131):606. PubMed ID: 9518917
    [No Abstract]   [Full Text] [Related]  

  • 35. On the mathematical basis of Zelen's prerandomized designs.
    Brunner E; Neumann N
    Methods Inf Med; 1985 Jul; 24(3):120-30. PubMed ID: 4033442
    [No Abstract]   [Full Text] [Related]  

  • 36. Using a balancing procedure in multicenter clinical trials. Simulation of patient allocation based on a trial of ventilation tubes for otitis media with effusion in infants.
    Rovers MM; Straatman H; Zielhuis GA; Ingels K; van der Wilt GJ
    Int J Technol Assess Health Care; 2000; 16(1):276-81. PubMed ID: 10815372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient treatment allocation in two-way nested designs.
    Lemme F; van Breukelen GJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):494-512. PubMed ID: 24030312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ensuring balanced distribution of prognostic factors in treatment outcome research.
    Stout RL; Wirtz PW; Carbonari JP; Del Boca FK
    J Stud Alcohol Suppl; 1994 Dec; 12():70-5. PubMed ID: 7723001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
    Bonangelino P; Irony T; Liang S; Li X; Mukhi V; Ruan S; Xu Y; Yang X; Wang C
    J Biopharm Stat; 2011 Sep; 21(5):938-53. PubMed ID: 21830924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [n or more in clinical trials? Zelen's models for randomization].
    Taube A
    Lakartidningen; 1994 Mar; 91(10):977-82. PubMed ID: 8139323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.